MedPath

Effect of Acute Arterial Hypertension on Morphine's Requirements and Postsurgical Pain.

Phase 4
Completed
Conditions
Hypertensive Disease
Pain, Postoperative
Interventions
Other: SBP 20-30% over baseline
Other: SBP 20-30% under baseline
Registration Number
NCT01897155
Lead Sponsor
Pontificia Universidad Catolica de Chile
Brief Summary

The purpose of this randomized clinical trial is to evaluate the effect of acute arterial hypertension maintained during surgery on morphine's requirements in patients undergoing laparoscopic cholecystectomy

Detailed Description

The high arterial blood pressure has been correlated with an increase in pain threshold in animal and humans. One of the explanations to this phenomenon is a baroreceptor activity and vasopressin release at the level of spinal cord dorsal horn and hypothalamus.

As far as we know, there is only one study about the effect of chronic hypertension on postoperative pain and none with acute hypertension. We therefore decided to conduct a randomized controlled trial to evaluate the effect of acute hypertension on postoperative morphine's requirements.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • American Society of Anesthesiology patient classification status(ASA) I-II
  • Between 20 and 60 years of age
  • Programed for elective laparoscopic cholecystectomy
Exclusion Criteria
  • History of arterial hypertension
  • Baseline blood pressure over 139/89
  • Use of opioids and any analgesic drug during the last 24 hours before surgery
  • Chronic use of nonsteroidal antiinflammatory
  • BMI > 34.9
  • History of drug or alcohol abuse
  • Use of medications that interfere in the central nervous system
  • Adverse reactions to the drugs used in the study
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SBP 20-30% under baselineSBP 20-30% over baselineInduction of anesthesia was performed with remifentanil, pentothal 3 mg/kg and atracurium 0.5 mg/Kg. Anaesthesia was maintained with remifentanil (0.4 ug/Kg/min) and isoflurane adjusted to bispectral index (40-60). Patients received a phenylephrine infusion to maintain systolic blood pressure (SBP) 20% to 30% under baseline. The lower limit of SBP was 75 mmHg. In the recovery room, morphine was administered routinely at doses of 3 mg IV every 15 minutes until pain was less than 4 estimated by visual analog scale (VAS). VAS and pain threshold with von Frey filaments were assessed at 2, 6, 12 and 24 postoperative hours. All patients, received ketorolac 30 mg IV every 8 hours and intravenous morphine administered by patient controlled analgesia system (PCA) during the first 24 hours.
SBP 20-30% over baselineSBP 20-30% under baselineInduction of anesthesia was performed with remifentanil, pentothal 3 mg/kg and atracurium 0.5 mg/Kg. Anaesthesia was maintained with remifentanil (0.4 ug/Kg/min) and isoflurane adjusted to bispectral index(40-60). Patients received a phenylephrine infusion in order to maintain systolic blood pressure (SBP) 20% to 30% over baseline. The upper limit of SBP was 165 mmHg. In the recovery room, morphine was administered routinely at doses of 3 mg IV every 15 minutes until pain was less than 4 estimated by visual analog scale (VAS). VAS and pain threshold with von Frey filaments were assessed at 2, 6, 12 and 24 postoperative hours. All patients, received ketorolac 30 mg IV every 8 hours and intravenous morphine administered by patient controlled analgesia system (PCA) during the first 24 hours.
Primary Outcome Measures
NameTimeMethod
Morphine requirement post laparoscopic cholecystectomyFirst 24 hours postoperative

Measure of morphine consumption during the first 24 postoperative hours in patients undergoing laparoscopic cholecystectomy.

Secondary Outcome Measures
NameTimeMethod
Effects of acute hypertension in pain scoresFirst 24 hours postoperative

Trial Locations

Locations (1)

Hospital Clinico Pontificia Universidad Catolica

🇨🇱

Santiago, Region Metropolitana, Chile

© Copyright 2025. All Rights Reserved by MedPath